Literature DB >> 2449109

Islet cell tumors metastatic to the liver: effective palliation by sequential hepatic artery embolization.

J A Ajani1, C H Carrasco, C Charnsangavej, N A Samaan, B Levin, S Wallace.   

Abstract

The value of sequential percutaneous hepatic artery embolization with polyvinyl alcohol particles was examined in 22 patients with islet cell carcinoma metastatic to the liver. Nine patients had gastrinoma, 2 had glucagonoma, and 11 had no discernible hormonal secretions or syndromes. Ninety-seven embolizations were done with a median number of 4 (range, 1 to 12) per patient. The interval between embolizations ranged from 1 to 8 months. Twelve of twenty evaluable patients had a partial remission, frequently associated with subjective improvement and decrease in hormone levels. The projected median survival of all 22 patients from the initiation of embolization is 33.7 months (range, 1 to 72). Nausea, vomiting, fever, and abdominal pain occurred with each embolization and subsided usually by day 10 (range, 3 to 35). Sequential hepatic artery occlusion is an effective method for prolonged palliation in this selected group of patients.

Entities:  

Mesh:

Year:  1988        PMID: 2449109     DOI: 10.7326/0003-4819-108-3-340

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  22 in total

1.  Liver Metastases.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

2.  Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report.

Authors:  C C Case; K Wirfel; R Vassilopoulou-Sellin
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

3.  Regional chemotherapy for hepatic tumors--new hope on the horizon.

Authors:  M Kemeny
Journal:  West J Med       Date:  1989-09

4.  A woman with metastatic pancreatic neuroendocrine tumor.

Authors:  Alexander N Shoushtari; Anne M Covey; Ghazi Zaatari; Ali Shamseddine; Andrew S Epstein; Ali Haydar; Mohamed Naghy; Deborah Mukherji; David P Kelsen; Ghassan K Abou-Alfa; Eileen M O'Reilly
Journal:  Gastrointest Cancer Res       Date:  2014-01

Review 5.  Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.

Authors:  Magaly Zappa; Mohamed Abdel-Rehim; Olivia Hentic; Marie-Pierre Vullierme; Philippe Ruszniewski; Valérie Vilgrain
Journal:  Target Oncol       Date:  2012-05-22       Impact factor: 4.493

Review 6.  Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.

Authors:  Sayee Sundar Alagusundaramoorthy; Roberto Gedaly
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 7.  Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.

Authors:  Sanjay Gupta
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

Review 8.  [Drug therapy of endocrine neoplasms. Part II: Malignant gastrinomas, insulinomas, glucagonomas, carcinoids and other tumors].

Authors:  M Schott; W A Scherbaum; J Feldkamp
Journal:  Med Klin (Munich)       Date:  2000-02-15

9.  Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.

Authors:  S Grozinsky-Glasberg; G Kaltsas; M Kaltsatou; N Lev-Cohain; A Klimov; V Vergadis; I Uri; A I Bloom; D J Gross
Journal:  Endocrine       Date:  2018-01-30       Impact factor: 3.633

Review 10.  Transcatheter therapy for malignant neoplasms.

Authors:  D M Coldwell; J E Mortimer
Journal:  West J Med       Date:  1989-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.